NCT02351960 Dexlansoprazole in Asian Participants With Gastroesophageal Reflux Disease Status COMPLETED Phase PHASE4
NCT02348658 A Phase 1 Food Effect Study of TAK-536TCH Final Formulation Tablet Status COMPLETED Phase PHASE1
NCT02346344 Outpatient Characterization of the Variability of Insulin Secretory Parameters in the Meal Tolerance and the Maximal Stimulation Tests of Subjects With Type 2 Diabetes Mellitus Status COMPLETED Phase N/A
NCT02338713 Effect of Calcium 500 mg and Vitamin D3 1000 IU Chewable Tablet on Intestinal Calcium Absorption Status COMPLETED Phase PHASE1
NCT02337946 Safety and Efficacy Study of mFOLFOX6 + Panitumumab Combination Therapy and 5-FU/LV + Panitumumab Combination Therapy in Participants With Chemotherapy-naïve Unresectable Advanced Recurrent Colorectal Carcinoma Status COMPLETED Phase PHASE2
NCT02337764 A Long-term, Phase 3 Study of TVP-1012 (1 mg) in Levodopa Treated Parkinson's Disease Participants Status COMPLETED Phase PHASE3
NCT02337751 A Phase 3, Long-term, Extension Study of TVP-1012 (1 mg) in Early Parkinson's Disease Participants Status COMPLETED Phase PHASE3
NCT02337738 A Phase 2/3 Study of TVP-1012 at 0.5 mg or 1 mg in Levodopa Treated Parkinson's Disease Participants Status COMPLETED Phase PHASE2/PHASE3
NCT02337725 A Phase 3 Study of TVP-1012 (1 mg) in Early Parkinson's Disease Patients Status COMPLETED Phase PHASE3
NCT02334982 Safety, Tolerability and Pharmacokinetics of Escalating Single Doses of TAK-137 in Healthy Participants Status COMPLETED Phase PHASE1
NCT02332824 A Phase 2 Dose-finding Study of TAK-272 in Participants With Type 2 Diabetes Mellitus and Microalbuminuria Status COMPLETED Phase PHASE2
NCT02324569 A Phase 4, Randomized, Double-blind, Parallel-group, Comparative Study and a Phase 4, Open-label, Long-term Study of SYR-472 (100 mg) in Combination With Insulin in Patients With Type 2 Diabetes Status COMPLETED Phase PHASE3
NCT02313155 Phase 1/2 Study of TAK-850 Subcutaneous Injection in Healthy Adults Status COMPLETED Phase PHASE1/PHASE2
NCT02312258 A Study of Oral Ixazomib Maintenance Therapy in Participants With Newly Diagnosed Multiple Myeloma (NDMM) Not Treated With Stem Cell Transplantation (SCT) Status COMPLETED Phase PHASE3
NCT02302092 An Efficacy and Safety of Flomoxef Versus Cefepime in the Treatment of Participants With Urinary Tract Infections Status TERMINATED Phase PHASE3
NCT02302066 Safety and Immunogenicity of Different Schedules of Takeda's Tetravalent Dengue Vaccine Candidate (TDV) in Healthy Participants Status COMPLETED Phase PHASE2